Cargando…

Enhanced Cytotoxic Activity of Mitochondrial Mechanical Effectors in Human Lung Carcinoma H520 Cells: Pharmaceutical Implications for Cancer Therapy

Cancer cell mitochondria represent an attractive target for oncological treatment as they have unique hallmarks that differ from their healthy counterparts, as the presence of a stronger membrane potential that can be exploited to specifically accumulate cytotoxic cationic molecules. Here, we explor...

Descripción completa

Detalles Bibliográficos
Autores principales: González Rubio, Sergio, Montero Pastor, Nuria, García, Carolina, Almendro-Vedia, Víctor G., Ferrer, Irene, Natale, Paolo, Paz-Ares, Luis, Lillo, M. Pilar, López-Montero, Iván
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242888/
https://www.ncbi.nlm.nih.gov/pubmed/30483474
http://dx.doi.org/10.3389/fonc.2018.00514
_version_ 1783371860770029568
author González Rubio, Sergio
Montero Pastor, Nuria
García, Carolina
Almendro-Vedia, Víctor G.
Ferrer, Irene
Natale, Paolo
Paz-Ares, Luis
Lillo, M. Pilar
López-Montero, Iván
author_facet González Rubio, Sergio
Montero Pastor, Nuria
García, Carolina
Almendro-Vedia, Víctor G.
Ferrer, Irene
Natale, Paolo
Paz-Ares, Luis
Lillo, M. Pilar
López-Montero, Iván
author_sort González Rubio, Sergio
collection PubMed
description Cancer cell mitochondria represent an attractive target for oncological treatment as they have unique hallmarks that differ from their healthy counterparts, as the presence of a stronger membrane potential that can be exploited to specifically accumulate cytotoxic cationic molecules. Here, we explore the selective cytotoxic effect of 10-N-nonyl acridine orange (NAO) on human lung carcinoma H520 cells and compare them with healthy human lung primary fibroblasts. NAO is a lipophilic and positively charged molecule that promotes mitochondrial membrane adhesion that eventually leads to apoptosis when incubated at high micromolar concentration. We found an enhanced cytotoxicity of NAO in H520 cancer cells. By means Fluorescence lifetime imaging microscopy (FLIM) we also confirmed the formation of H-dimeric aggregates originating from opposing adjacent membranes that interfere with the mitochondrial membrane structure. Based on our results, we suggest the mitochondrial membrane as a potential target in cancer therapy to mechanically control the cell proliferation of cancer cells.
format Online
Article
Text
id pubmed-6242888
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62428882018-11-27 Enhanced Cytotoxic Activity of Mitochondrial Mechanical Effectors in Human Lung Carcinoma H520 Cells: Pharmaceutical Implications for Cancer Therapy González Rubio, Sergio Montero Pastor, Nuria García, Carolina Almendro-Vedia, Víctor G. Ferrer, Irene Natale, Paolo Paz-Ares, Luis Lillo, M. Pilar López-Montero, Iván Front Oncol Oncology Cancer cell mitochondria represent an attractive target for oncological treatment as they have unique hallmarks that differ from their healthy counterparts, as the presence of a stronger membrane potential that can be exploited to specifically accumulate cytotoxic cationic molecules. Here, we explore the selective cytotoxic effect of 10-N-nonyl acridine orange (NAO) on human lung carcinoma H520 cells and compare them with healthy human lung primary fibroblasts. NAO is a lipophilic and positively charged molecule that promotes mitochondrial membrane adhesion that eventually leads to apoptosis when incubated at high micromolar concentration. We found an enhanced cytotoxicity of NAO in H520 cancer cells. By means Fluorescence lifetime imaging microscopy (FLIM) we also confirmed the formation of H-dimeric aggregates originating from opposing adjacent membranes that interfere with the mitochondrial membrane structure. Based on our results, we suggest the mitochondrial membrane as a potential target in cancer therapy to mechanically control the cell proliferation of cancer cells. Frontiers Media S.A. 2018-11-13 /pmc/articles/PMC6242888/ /pubmed/30483474 http://dx.doi.org/10.3389/fonc.2018.00514 Text en Copyright © 2018 González Rubio, Montero Pastor, García, Almendro-Vedia, Ferrer, Natale, Paz-Ares, Lillo and López-Montero. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
González Rubio, Sergio
Montero Pastor, Nuria
García, Carolina
Almendro-Vedia, Víctor G.
Ferrer, Irene
Natale, Paolo
Paz-Ares, Luis
Lillo, M. Pilar
López-Montero, Iván
Enhanced Cytotoxic Activity of Mitochondrial Mechanical Effectors in Human Lung Carcinoma H520 Cells: Pharmaceutical Implications for Cancer Therapy
title Enhanced Cytotoxic Activity of Mitochondrial Mechanical Effectors in Human Lung Carcinoma H520 Cells: Pharmaceutical Implications for Cancer Therapy
title_full Enhanced Cytotoxic Activity of Mitochondrial Mechanical Effectors in Human Lung Carcinoma H520 Cells: Pharmaceutical Implications for Cancer Therapy
title_fullStr Enhanced Cytotoxic Activity of Mitochondrial Mechanical Effectors in Human Lung Carcinoma H520 Cells: Pharmaceutical Implications for Cancer Therapy
title_full_unstemmed Enhanced Cytotoxic Activity of Mitochondrial Mechanical Effectors in Human Lung Carcinoma H520 Cells: Pharmaceutical Implications for Cancer Therapy
title_short Enhanced Cytotoxic Activity of Mitochondrial Mechanical Effectors in Human Lung Carcinoma H520 Cells: Pharmaceutical Implications for Cancer Therapy
title_sort enhanced cytotoxic activity of mitochondrial mechanical effectors in human lung carcinoma h520 cells: pharmaceutical implications for cancer therapy
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242888/
https://www.ncbi.nlm.nih.gov/pubmed/30483474
http://dx.doi.org/10.3389/fonc.2018.00514
work_keys_str_mv AT gonzalezrubiosergio enhancedcytotoxicactivityofmitochondrialmechanicaleffectorsinhumanlungcarcinomah520cellspharmaceuticalimplicationsforcancertherapy
AT monteropastornuria enhancedcytotoxicactivityofmitochondrialmechanicaleffectorsinhumanlungcarcinomah520cellspharmaceuticalimplicationsforcancertherapy
AT garciacarolina enhancedcytotoxicactivityofmitochondrialmechanicaleffectorsinhumanlungcarcinomah520cellspharmaceuticalimplicationsforcancertherapy
AT almendrovediavictorg enhancedcytotoxicactivityofmitochondrialmechanicaleffectorsinhumanlungcarcinomah520cellspharmaceuticalimplicationsforcancertherapy
AT ferrerirene enhancedcytotoxicactivityofmitochondrialmechanicaleffectorsinhumanlungcarcinomah520cellspharmaceuticalimplicationsforcancertherapy
AT natalepaolo enhancedcytotoxicactivityofmitochondrialmechanicaleffectorsinhumanlungcarcinomah520cellspharmaceuticalimplicationsforcancertherapy
AT pazaresluis enhancedcytotoxicactivityofmitochondrialmechanicaleffectorsinhumanlungcarcinomah520cellspharmaceuticalimplicationsforcancertherapy
AT lillompilar enhancedcytotoxicactivityofmitochondrialmechanicaleffectorsinhumanlungcarcinomah520cellspharmaceuticalimplicationsforcancertherapy
AT lopezmonteroivan enhancedcytotoxicactivityofmitochondrialmechanicaleffectorsinhumanlungcarcinomah520cellspharmaceuticalimplicationsforcancertherapy